Disease · EFO_1001782

dental pulp exposure

6 sourcesdiseases-2026-09-18-0.1.0

Cite this record

ConductScience Library. dental pulp exposure. Diseases, record EFO_1001782. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/EFO_1001782

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name: dental pulp exposure; Open Targets
Open Targets ID: EFO_1001782; Open Targets
Other names: pulp exposure; Open Targets
MeSH: D003789; MeSH
Highest stage of its drugs: Phase 1, for 2 of its 3 drugs, from ClinicalTrials.gov; Open Targets

Drugs3

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Drug	ChEMBL ID	Type	Open Targets' stage	Stage reported by	Reports	Of them trials	Trials shown here	Source
CURCUMIN	CHEMBL140	Small molecule	Phase 1	ClinicalTrials.gov	1	1	1	Drugs and targets
PROPOLIS WAX	CHEMBL4298075	Small molecule	Phase 1	ClinicalTrials.gov	1	1	1	Drugs and targets
CALCIUM HYDROXIDE	CHEMBL2106388	Small molecule	Unknown	ClinicalTrials.gov	2	2	2	Drugs and targets

Targets0

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

None in this release.

Trials3

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.

Trial	Title	Phase	Participants	Results first posted	Conditions	Drugs	Linked by	Source
NCT00812877	Pulp Capping With Two Different Agents	Not applicable	376	2015-05-25	Dental Pulp Exposure	CALCIUM HYDROXIDE	Its record names the disease	ClinicalTrials.gov
NCT03403985	Long-term Evaluation of Direct Pulp Capping	Not applicable	80		Dental Pulp Capping, Dental Caries Extending to Pulp	CALCIUM HYDROXIDE	Its record names the disease	ClinicalTrials.gov
NCT06029023	Clinical And Radiographic Evaluation Of Nano-Propolis, Nano-Curcumin and MTA as Direct Pulp Capping Agents in Young Permanant Teeth	Phase 1	54		Traumatic Pulp Exposure in Children	CURCUMIN, PROPOLIS WAX	Its record names the disease	ClinicalTrials.gov

Comparisons in its trials3

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Mineral Trioxide Aggregate vs Calcium Hydroxide: serious adverse events	2 of 195	1 of 181	376	NCT00812877	Trial comparisons
Mineral Trioxide Aggregate vs Calcium Hydroxide: Tooth Survival	158 of 183	130 of 175	358	NCT00812877	Trial comparisons
Mineral Trioxide Aggregate vs Calcium Hydroxide: Pulp Vitality	155 of 183	130 of 175	358	NCT00812877	Trial comparisons

Papers from its trials1

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it
23690353	RESULT	1

Source PubMed

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
Drug links and their checks, from Drugs and targets: 2026-09-18; Drugs and targets
ClinicalTrials.gov, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
PubMed, for the checks: 2026-11-06; PubMed
MeSH, for the checks: 2026-11-10; MeSH

Sources 6

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/EFO_1001782

GET https://conductscience.org/api/diseases/v1/EFO_1001782/drugs

API reference For AI assistants